Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2012
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012144519A1 Granules in liquid dosage form
10/26/2012WO2012144478A1 Tetrahydrothiazepine derivative
10/26/2012WO2012143813A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
10/26/2012WO2012143660A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/26/2012WO2012143416A2 Novel compounds
10/26/2012WO2012143041A1 Composition, method for its manufacture and use thereof
10/26/2012WO2012142930A1 Anti-fatty acid synthase polypeptide and use thereof
10/26/2012WO2012142678A1 Weight loss composition
10/26/2012WO2012119046A3 Heterocyclic compounds for the inhibition of pask
10/26/2012WO2012088038A3 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
10/26/2012WO2011112822A8 Implantable therapeutic device and methods of making
10/26/2012CA2855469A1 Compositions and methods for nutritional supplementation
10/26/2012CA2833623A1 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
10/26/2012CA2833547A1 Methods and compositions suitable for preventing and treating hyperleptinemia
10/26/2012CA2833339A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/26/2012CA2831380A1 Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
10/25/2012US20120270950 Alkaline decomposition product of hop extract and use thereof
10/25/2012US20120270933 Liquid statin formulation
10/25/2012US20120270929 Modulation of ttc39 expression to increase hdl
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270912 Substituted Indolealkanoic Acids
10/25/2012US20120270908 Substituted 3 -hydrozypyridines and pharmaceutical compositions thereof
10/25/2012US20120270901 Indene derivatives as pharmaceutical agents
10/25/2012US20120270899 Compositions and Methods for Treating Cardiovascular Diseases
10/25/2012US20120270893 Substituted acetyl-coa carboxylase inhibitors
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270890 Methods of Pancreatic Beta Cell Regeneration
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270870 Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270865 Heterocyclic compound
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270856 Heteroaryloxy quinazoline derivatives
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270842 Inhibitors of Diacylglycerol O-Acyltransferase 1 (DGAT-1) and Uses Thereof
10/25/2012US20120270832 Ketone accumulation inhibitor
10/25/2012US20120270814 Compositions and methods for reducing or preventing obesity
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270778 Compositions and Methods for Non-Invasive Treatment of Chronic Complications of Diabetes
10/25/2012US20120270777 Lactoferrin and gut neuronal health in adults and/or elderly
10/25/2012US20120270771 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
10/25/2012US20120269914 Plant extracts for treating skin diseases
10/25/2012US20120269913 Crude caffeine complex, improved food products using the crude caffeine complex, and methods of use thereof
10/25/2012US20120269911 Compositions and Method for Enhancing Insulin Activity
10/25/2012US20120269910 Method for Testing a Substance Which is Potentially Active in the Field of Lipolysis and its Mainly Cosmetic Use
10/25/2012US20120269890 Process for obtaining a rosuvastatin calcium composition and obtained product
10/25/2012US20120269888 Barrier composition
10/25/2012US20120269868 Compositions and methods for nutritional supplementation
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269796 Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes
10/25/2012US20120269793 Phytoestrogenic formulations for alleviation or prevention of hair loss
10/25/2012US20120269792 Eutectic-based self-nanoemulsified drug delivery system
10/25/2012US20120269790 Use of plant extracts as prebiotics, compositions and foods containing such extract
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/24/2012EP2514749A1 Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012EP2514483A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments
10/24/2012EP2514432A1 Sea cucumber compound preparation and preparation method thereof
10/24/2012EP2514425A1 Composition containing protopanaxatriol and protopanaxadiol
10/24/2012EP2514422A1 Elution-stabilized preparation
10/24/2012EP2514321A1 Liquid food composition
10/24/2012EP2513298A2 Beta-cell replication promoting compounds and methods of their use
10/24/2012EP2513109A1 Heterocyclic compounds and their uses
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513070A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012EP2512475A1 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases
10/24/2012EP2512471A1 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
10/24/2012EP2512267A1 Coffee treatment method
10/24/2012CN102753684A Mutant for increasing oleic acid content of soybean oil and fat, and responsible gene therefor
10/24/2012CN102753576A Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
10/24/2012CN102753545A Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012CN102753540A A4ss2 neuronal nicotinic acetylcholine receptor ligands
10/24/2012CN102753539A Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
10/24/2012CN102753192A Pharmaceutical composition for treating a metabolic syndrome
10/24/2012CN102753183A Agent for improving motility function
10/24/2012CN102753182A Concentrated therapeutic phospholipid compositions
10/24/2012CN102753170A Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
10/24/2012CN102753043A Nutritional compositions and methods for optimizing dietary acid-base potential
10/24/2012CN102746378A Anti-fatty acid synthetase polypeptide and its application
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
10/24/2012CN102746290A Thiazole compound and preparation method thereof
10/24/2012CN102746264A 7-benzyloxy hesperetin, preparation method and application thereof
10/24/2012CN102746220A Novel pyridine alkaloids, preparation process thereof, and the uses of the pyridine alkaloids
10/24/2012CN102746214A Novel indoline compounds
10/24/2012CN102746213A Cinnamamide histone deacetylase inhibitor, preparation method thereof, and application thereof
10/24/2012CN102744136A Preparation method for nanometre pearl powder
10/24/2012CN102743646A Medicinal composition for inspecting and preventing diabetes
10/24/2012CN102743599A Traditional Chinese medicine for treating diabetes
10/24/2012CN102743584A Traditional Chinese medicine for decreasing blood sugar and preparation method thereof
10/24/2012CN102743581A Diabetes mellitus traditional Chinese medicine foot bath prescription
10/24/2012CN102743578A Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction
10/24/2012CN102743547A Weight-reducing composition with obesity preventing effect and weight-reducing solution
10/24/2012CN102743540A Combined blood sugar-reduction formula
10/24/2012CN102743504A Chinese medicinal composition for reducing weight and lowering lipid
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 1298